IL-1ra administration does not improve cardiac function in patients with severe sepsis

Jean Louis Vincent; Gus J. Slotman; Paul An Van Leeuwen; M. P. Shelly; Stanley A. Nasraway; Alain Tenaillon; Joseph J. Bander; Gilberto Friedman

doi:10.1016/s0883-9441(99)90016-3

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2010

Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis*

Michiel E. Stegenga, Jean Louis Vincent, G. Matthew Vail, Jin Xie, Douglas J. Haney, Mark D. Williams, Gordon R. Bernard, Tom van der Poll

Article1998

Heliox does not improve FEV1 in acute asthma patients

P. Richard Verbeek, Anil K Chopra

Article2003

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

E. Wesley Ely, Pierre‐François Laterre, Derek C. Angus, Jeffrey D. Helterbrand, Howard Levy, Jean-François Dhainaut, Jean Louis Vincent, William L. Macias, Gordon R. Bernard

Article2011

Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels

Raymond C.S. Seet, Jetty Chung‐Yung Lee, Erle C.H. Lim, Amy M.L. Quek, Hui-Wen Huang, Shan Huang, Woan Foon Looi, Lee Hua Long, Barry Halliwell

Atherosclerosis

Chapter in a book2020

Does the timing of antibiotic administration matter in sepsis?

Ithan D. Peltan, Jean Louis Vincent